Drug intelligence / Profile preview

Livalo HI

Development stage: Unknown
Lead developer: JW Pharmaceutical
Modality: Small Molecules
Administration: Oral

Overview

**Livalo HI** is an oral fixed-dose triple-combination tablet developed and manufactured by JW Pharmaceutical for patients requiring concurrent treatment of hyperlipidemia and hypertension. It combines pitavastatin, an HMG-CoA reductase inhibitor that lowers hepatic cholesterol synthesis; valsartan, an angiotensin II type 1 receptor blocker; and amlodipine, a dihydropyridine L-type calcium-channel blocker. Approved in South Korea in 2025, it is supplied in multiple pitavastatin/valsartan/amlodipine strengths and is administered once daily. ([m.jw-pharma.co.kr](https://m.jw-pharma.co.kr/mobile/pharma/en/randd/m_research_pipeline.jsp))

Brand names: Livalo HILivalo High리바로하이정
Other names: amlodipine + pitavastatin + valsartan

Targets

HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)AGTR1 (Angiotensin II Type-1 receptor)ITGAL (Integrin alpha L (CD11a))

Beyond the preview

Go deeper on Livalo HI.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Livalo HI.

Explore the full profile